Selective targeting of histone modification fails to prevent graft versus host disease after hematopoietic cell transplantation

por Alahmari, Bader, Cooper, Matthew, Ziga, Edward, Ritchey, Julie, DiPersio, John F., Choi, Jaebok
Publicado 2018

Pharmacologic Blockade of JAK1/JAK2 Reduces GvHD and Preserves the Graft-Versus-Leukemia Effect

por Choi, Jaebok, Cooper, Matthew L., Alahmari, Bader, Ritchey, Julie, Collins, Lynne, Holt, Matthew, DiPersio, John F.
Publicado 2014

CD7-deleted hematopoietic stem cells can restore immunity after CAR T cell therapy

por Kim, Miriam Y., Cooper, Matthew L., Jacobs, Miriam T., Ritchey, Julie K., Hollaway, Julia, Fehniger, Todd A., DiPersio, John F.
Publicado 2021

Liposomal phytohemagglutinin: In vivo T‐cell activator as a novel pan‐cancer immunotherapy

por Alhallak, Kinan, Sun, Jennifer, Muz, Barbara, Jeske, Amanda, O’Neal, Julie, Ritchey, Julie K., Achilefu, Samuel, DiPersio, John F., Azab, Abdel Kareem
Publicado 2022

Baricitinib with cyclosporine eliminates acute graft rejection in fully mismatched skin and heart transplant models

por Abboud, Ramzi, Kim, Sena, Staser, Karl, Jayasinghe, Reyka G., Lim, Sora, Amatya, Parmeshwar, Frye, C. Corbin, Kopecky, Benjamin, Ritchey, Julie, Gao, Feng, Lavine, Kory, Kreisel, Daniel, DiPersio, John F., Choi, Jaebok
Publicado 2023

Baricitinib-induced blockade of interferon gamma receptor and interleukin-6 receptor for the prevention and treatment of graft-versus-host disease

por Choi, Jaebok, Cooper, Matthew L., Staser, Karl, Ashami, Kidist, Vij, Kiran R., Wang, Bing, Marsala, Lynne, Niswonger, Jessica, Ritchey, Julie, Alahmari, Bader, Achilefu, Samuel, Tsunoda, Ikuo, Schroeder, Mark A., DiPersio, John F.
Publicado 2018

Ablation of VLA4 in multiple myeloma cells redirects tumor spread and prolongs survival

por Hathi, Deep, Chanswangphuwana, Chantiya, Cho, Nicholas, Fontana, Francesca, Maji, Dolonchampa, Ritchey, Julie, O’Neal, Julie, Ghai, Anchal, Duncan, Kathleen, Akers, Walter J., Fiala, Mark, Vij, Ravi, DiPersio, John F., Rettig, Michael, Shokeen, Monica
Publicado 2022

A long-acting interleukin-7, rhIL-7-hyFc, enhances CAR T cell expansion, persistence, and anti-tumor activity

por Kim, Miriam Y., Jayasinghe, Reyka, Devenport, Jessica M., Ritchey, Julie K., Rettig, Michael P., O’Neal, Julie, Staser, Karl W., Kennerly, Krista M., Carter, Alun J., Gao, Feng, Lee, Byung Ha, Cooper, Matthew L., DiPersio, John F.
Publicado 2022

An “off-the-shelf” CD2 universal CAR-T therapy for T-cell malignancies

por Xiang, Jingyu, Devenport, Jessica M., Carter, Alun J., Staser, Karl W., Kim, Miriam Y., O’ Neal, Julie, Ritchey, Julie K., Rettig, Michael P., Gao, Feng, Rettig, Garrett, Turk, Rolf, Lee, Byung Ha, Cooper, Matthew L., DiPersio, John F.
Publicado 2023

Duvelisib for Critically Ill Patients With Coronavirus Disease 2019: An Investigator-Initiated, Randomized, Placebo-Controlled, Double-Blind Pilot Trial

por Goldsmith, Scott R, Covut, Fahrettin, Fiala, Mark, Xiang, Zhifu, Iqbal, Zahid, Moore, Nathan, Bradtke, Elizabeth, Christen, Brandon, Rettig, Michael P, Christ, Stephanie, Gehrs, Leah, Street, Emily, Wallace, Nicholas, Ritchey, Julie, Gao, Feng, Pachter, Jonathan, Parikh, Bijal, Dubberke, Erik R, DiPersio, John F
Publicado 2023

CS1 CAR-T targeting the distal domain of CS1 (SLAMF7) shows efficacy in high tumor burden myeloma model despite fratricide of CD8+CS1 expressing CAR-T cells

por O’Neal, Julie, Ritchey, Julie K., Cooper, Matthew L., Niswonger, Jessica, Sofía González, L., Street, Emily, Rettig, Michael P., Gladney, Susan W., Gehrs, Leah, Abboud, Ramzi, Prior, Julie L., Haas, Gabriel J., Jayasinghe, Reyka G., Ding, Li, Ghobadi, Armin, Vij, Ravi, DiPersio, John F.
Publicado 2022

Anti-myeloma efficacy of CAR-iNKT is enhanced with a long-acting IL-7, rhIL-7-hyFc

por O’Neal, Julie, Cooper, Matthew L., Ritchey, Julie K., Gladney, Susan, Niswonger, Jessica, González, L. Sofía, Street, Emily, Haas, Gabriel J., Carter, Alun, Amayta, Parmeshwar N., Gao, Feng, Lee, Byung Ha, Choi, Donghoon, Berrien-Elliott, Melissa, Zhou, Alice, Fehniger, Todd A., Rettig, Mike P., DiPersio, John F.
Publicado 2023

An ‘off-the-shelf’ fratricide-resistant CAR-T for the treatment of T cell hematologic malignancies

por Cooper, Matthew L., Choi, Jaebok, Staser, Karl, Ritchey, Julie K., Devenport, Jessica M., Eckardt, Kayla, Rettig, Michael P., Wang, Bing, Eissenberg, Linda G., Ghobadi, Armin, Gehrs, Leah N., Prior, Julie L., Achilefu, Samuel, Miller, Christopher A., Fronick, Catrina C., O’Neal, Julie, Gao, Feng, Weinstock, David M., Gutierrez, Alejandro, Fulton, Robert S., DiPersio, John F
Publicado 2018

Clonal evolution in relapsed acute myeloid leukemia revealed by whole genome sequencing

por Ding, Li, Ley, Timothy J., Larson, David E., Miller, Christopher A., Koboldt, Daniel C., Welch, John S., Ritchey, Julie K., Young, Margaret A., Lamprecht, Tamara, McLellan, Michael D., McMichael, Joshua F., Wallis, John W., Lu, Charles, Shen, Dong, Harris, Christopher C., Dooling, David J., Fulton, Robert S., Fulton, Lucinda L., Chen, Ken, Schmidt, Heather, Kalicki-Veizer, Joelle, Magrini, Vincent J., Cook, Lisa, McGrath, Sean D., Vickery, Tammi L., Wendl, Michael C., Heath, Sharon, Watson, Mark A., Link, Daniel C., Tomasson, Michael H., Shannon, William D., Payton, Jacqueline E., Kulkarni, Shashikant, Westervelt, Peter, Walter, Matthew J., Graubert, Timothy A., Mardis, Elaine R., Wilson, Richard K., DiPersio, John F.
Publicado 2012